Vir Biotechnology Inc (VIR)

Financial leverage ratio

		Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Total assets	US$ in thousands	1,398,810	1,498,360	1,669,560	1,793,970	1,960,090	2,044,900	2,243,870	2,665,940	2,802,090	2,695,970	2,618,990	2,887,130	1,954,270	1,210,210	1,057,580	1,135,580	918,761	943,259	672,238	477,114
Total stockholders’ equity	US$ in thousands	1,150,380	1,240,730	1,433,670	1,547,360	1,590,240	1,675,080	1,810,210	1,970,760	2,077,960	2,149,860	1,952,010	2,001,010	1,431,850	876,274	737,325	650,951	716,852	812,355	563,779	380,333
Financial leverage ratio		1.22	1.21	1.16	1.16	1.23	1.22	1.24	1.35	1.35	1.25	1.34	1.44	1.36	1.38	1.43	1.74	1.28	1.16	1.19	1.25

December 31, 2024 calculation

Financial leverage ratio = Total assets ÷ Total stockholders’ equity
= $1,398,810K ÷ $1,150,380K
= 1.22

The financial leverage ratio of Vir Biotechnology Inc has shown some fluctuations over the past few years. The ratio indicates the company's mix of debt and equity in its capital structure.

The financial leverage ratio decreased from 1.25 as of March 31, 2020, to 1.19 as of June 30, 2020, and continued to decline to 1.16 by September 30, 2020. However, there was an increase to 1.28 by December 31, 2020. The ratio then experienced a significant jump to 1.74 by March 31, 2021 and gradually decreased to 1.22 by December 31, 2023.

From December 31, 2023 through December 31, 2024, the financial leverage ratio remained relatively stable, ranging between 1.16 and 1.22.

Overall, the financial leverage ratio trended upwards in the initial years, indicating a higher reliance on debt to finance the company's operations. However, in the latter years, the ratio showed more stability at around 1.2, suggesting a more balanced capital structure with a mix of debt and equity.